Dupilumab monotherapy for 1 year provides sustained improvement in Dermatology Life Quality Index in adults with moderate-to-severe atopic dermatitis optimally responding at week 16
BRITISH JOURNAL OF DERMATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要